Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
118.4m
Last Price
$3.48
52-Week Range
$2.32 - $5.4566
08/28/2026 08:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808